GLP-1 agonists are medications that mimic the glucagon-like peptide-1 hormone to help regulate blood sugar and appetite. Starting therapy requires careful assessment of medical need, current health status, and a structured introduction to minimize side effects. This guide covers the practical timing and process for beginning treatment.
When and How to Start 1
Clinicians typically evaluate starting a GLP-1 agonist when lifestyle measures alone have not achieved target glycemic control or weight goals. The initial decision rests on lab values such as A1C levels above 7 percent, BMI thresholds, and the presence of related conditions like cardiovascular risk. The first step involves confirming no contraindications such as personal or family history of medullary thyroid carcinoma or pancreatitis. Once cleared, therapy begins at the lowest available dose to allow the body to adjust.
When and How to Start GLP 10
Dose escalation follows a fixed schedule after the starting dose proves tolerable. For agents that reach a 10 mg or equivalent maintenance level, the increase occurs only after four weeks at each prior step. Patients monitor for gastrointestinal effects and report persistent nausea or vomiting before any upward adjustment. Blood work and follow-up visits confirm that kidney function and other markers remain stable during titration.
Why It Matters
Proper timing reduces the chance of early discontinuation due to side effects and supports steady progress toward metabolic goals. Beginning too soon without adequate preparation can lead to unnecessary discomfort, while delaying when criteria are met may allow disease progression. Structured initiation also helps clinicians track individual response patterns and adjust the overall care plan.
How to Start a GLP-1 Agonist: Practical Steps
- Schedule a full medical review including recent labs and medication list.
- Discuss expectations and potential adjustments to diet or activity.
- Receive training on injection technique or oral administration if applicable.
- Begin at the lowest dose and log symptoms daily for the first two weeks.
- Attend the scheduled follow-up to review tolerance before any dose change.
Titration Overview
| Phase | Typical Duration | Focus |
|---|---|---|
| Initial low dose | 4 weeks | Assess tolerance and establish routine |
| First increase | 4 weeks | Monitor response and side effects |
| Maintenance level | Ongoing | Maintain benefits with periodic checks |
FAQ
What preparation is needed before the first dose?
Preparation includes a complete review of medical history, current medications, and baseline laboratory results. Patients should also receive clear instructions on storage, injection sites, and what symptoms warrant immediate contact with their care team.
How long does the starting phase last before reaching a stable dose?
The starting phase generally spans eight to twelve weeks, depending on the specific agent and individual tolerance. Each increase is held for at least four weeks to allow assessment of both benefits and adverse effects before moving forward.
Can existing oral diabetes medications continue during initiation?
Many patients continue other oral agents, but the prescriber may adjust doses to avoid hypoglycemia. Coordination with the full care team ensures all medications remain balanced as the GLP-1 agonist takes effect.
Last updated: October 9, 2026